Background Positron emission tomography (PET) scanning is an important diagnostic
imaging technique used in disease diagnosis, therapy planning, treatment monitoring, and …

Positron emission tomography (PET) is a non-invasive imaging technology employed to
describe metabolic, physiological, and biochemical processes in vivo. These include …

Objective: Full quantification of dynamic positron emission tomography (PET) data requires
the knowledge of tracer concentration in the arterial plasma. However, its accurate …

Purpose Radiomics has revolutionized clinical research by enabling objective
measurements of imaging-derived biomarkers. However, the true potential of radiomics …

Background Kinetic modelling of dynamic PET typically requires knowledge of the arterial
radiotracer concentration (arterial input function, AIF). Its accurate determination is very …

Quantification of physiological parameters in preclinical pharmacokinetic studies based on
nuclear imaging requires the monitoring of arterial radioactivity over time, known as the …

For quantitative analysis and bio-kinetic modeling of positron emission
tomography/computed tomography (PET/CT) data, the determination of the temporal blood …

The development of radiopharmaceuticals for positron emission tomography (PET) is an
emerging area of research in neuroscience that allows for the early and differential …

Purpose Preclinical dynamic brain PET studies remain hampered by the limitations related
to the measurement of the arterial input function (AIF). In this regard, the use of an arterial …

Parkinson's disease (PD) is one of the most common neurodegenerative diseases
worldwide. The use of animal, especially rodent, models is of utmost importance to expand …